home / stock / mrnty / mrnty news
Medicrea International ADR ( OTCQX:MRNTY ): FY Net loss of €15.6M. More news on: Medicrea International ADR, Medicrea International, Earnings news and commentary, Healthcare stocks news, , Read more ...
MEDICREA ® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ® ASI (Adaptive Spine Intelligence...
Objective of 5,000 UNiD™ Surgeries Exceeded With 5,040 Surgeries Performed on a Cumulative Basis at the End of 2019 Continued Strong Growth With UNiD™ Activity in 2019: +55% in the USA and +48% Globally vs 2018 2019 Sales: € 32.7M, +11% (+8% at Constant Ex...
Medicrea International SA ( OTCQX:MRNTY ): Q1 EBITDA of €0.3M More news on: Medicrea International SA, Earnings news and commentary, Healthcare stocks news, , Read more ...
Medicrea International SA ( OTCQX:MRNTY ): FY Net loss of -€11.8M. Revenue of €32.3M (+19.2% Y/Y) Press Release More news on: Medicrea International SA, Earnings news and commentary, Healthcare stocks news, ,
News, Short Squeeze, Breakout and More Instantly...
Medicrea International ADR Company Name:
MRNTY Stock Symbol:
OTCMKTS Market:
MEDICREA ® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ® ASI (Adaptive Spine Intelligence...
Objective of 5,000 UNiD™ Surgeries Exceeded With 5,040 Surgeries Performed on a Cumulative Basis at the End of 2019 Continued Strong Growth With UNiD™ Activity in 2019: +55% in the USA and +48% Globally vs 2018 2019 Sales: € 32.7M, +11% (+8% at Constant Ex...